Prevalence of Obesity and Metabolic Syndrome in Children with Type 1 Diabetes: A comparative assessment based on criteria established by WHO, IDF and NCEP
To determine the prevalence of obesity and metabolic syndrome (MetS) in children and adolescents with type 1 diabetes (T1D) and to compare widely accepted and used diagnostic criteria for metabolic syndrome established by IDF, WHO and NCEP-ATPIII. We conducted a descriptive, cross sectional study including T1D patients between 8-18 years of age. Modified criteria of IDF, WHO and NCEP-ATPIII were used to determine the prevalence of MetS. Hospital records were analyzed to determine related risk factors with MetS. The study included 200 patients with T1D (52% boys). Of these, 18% were overweight/obese (BMI percentile ≥ %85). MetS prevalence was found as 10.5%, 8.5% and 13.5% according to IDF, WHO and NCEP criteria, respectively. There were no statistically significant differences in age, gender, family history of T1D and T2D, pubertal stage, duration of diabetes, A1C levels and daily insulin doses between patients with or without MetS. In a total of 36 overweight or obese T1D patients, the prevalence of MetS was 44.4%, 38.8% and 44.4% according to IDF, WHO and NCEP-ATPIII criteria, respectively. Obesity prevalence of our T1D cohort is similar to healthy population in the same ages. Prevalence of MetS is higher in children and adolescents with T1D compared to the obese population in our country. Our study suggests that IDF criteria are more suitable for the diagnosis of MetS in children and adolescents with T1D.